Across TCGA pan-cancer cohorts, LINC01626 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of LINC01626’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where LINC01626 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01626 is over-expressed in tumor, although a few such as BRCA and LUAD show the opposite, repressed pattern.

KICH, BRCA, and LUAD are the cancer types where LINC01626 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01626 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.112	.003	4	view →
BRCA	All	All	−0.044	.002	4	view →
LUAD	Male	All	−0.034	.039	1	view →
THCA	All	II,III,IV	+0.029	.044	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: LINC01626 RNA expression & survival · all LINC01626 data types